THE BEST SIDE OF SITUS JUDI MBL77

Not all clients with CLL demand therapy. Regardless of all the latest advancements, the iwCLL even now endorses watchful observation for sufferers with asymptomatic condition.86 This advice is based on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 B